UK Companies House feature
RENISHAW NEURO SOLUTIONS LTD
Profile
- Company number
- 10375761
- Status
- Active
- Incorporation
- 2016-09-14
- Last accounts made up
- 2024-06-30
- Account category
- FULL
- Primary SIC
- 26600
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In preparing these financial statements, the Directors have adopted the going concern basis. The Company's parent undertaking, Renishaw plc, has provided a letter of support in meeting financial obligations for a period to 31 May 2026.”
Subsidiaries
- Renishaw Mayfield Sarl · 100% held · France · neurosurgery business
Significant events
- “On 27 February 2025 Renishaw plc, the ultimate parent, announced it would enter a consultation period over the proposal to close the drug delivery aspect of Renishaw Neuro Solutions Limited.”
- “On 01 April 2025, following the consultation period, it was announced that Renishaw plc will move forward with its proposal to close the drug delivery aspect of the Company. The closure is expected to take place by the end of 30 June 2025.”
- “Due to the proposal, the company has recognised a full impairment of £2,020,342 against intangible assets as the assets relate to drug delivery. An impairment of £29,312 has been recognised against tangible fixed assets, and the stock has been written down to its net realisable value, with a charge of £230,974 recognised.”
- “An additional c.£1,000,000 is expected to be incurred related to the closure of Drug Delivery.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CALLANAN, Louise | Director | 2025-11-26 | Jan 1975 | Irish |
| SAUNDERS, Marc Thomas Berkeley | Director | 2025-05-01 | Aug 1968 | British |
| TURL, Lee | Director | 2025-05-01 | Sep 1978 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| RICHARDS-GARCIA, Vilma Constanza | Secretary | 2017-08-26 | 2023-11-15 |
| TANG, Norma Shau Yee | Secretary | 2016-12-12 | 2017-08-26 |
| DEER, Daniel John | Director | 2017-08-23 | 2020-02-03 |
| JONES, Rupert Peregrin | Director | 2017-08-23 | 2025-05-01 |
| ROBERTS, Allen Christopher George | Director | 2016-12-12 | 2025-11-26 |
| SKINNER, Paul Jonathan | Director | 2017-08-23 | 2026-03-26 |
| THORNTON, Bryan Anthony | Director | 2016-09-14 | 2016-12-12 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Renishaw Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-12-16 | Active |
| Renishaw Medical Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2017-08-23 | Ceased 2019-12-16 |
| Renishaw Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-12-12 | Ceased 2017-08-23 |
| Cfs Secretaries Limited | Corporate entity | Shares 75–100%, Appoints directors, Significant influence | 2016-09-14 | Ceased 2016-12-12 |
| Mr Bryan Anthony Thornton | Individual | Appoints directors, Significant influence | 2016-09-14 | Ceased 2016-12-12 |
Filing timeline
Last 20 of 47 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-08 | TM01 | officers | termination director company with name termination date |
| 2025-12-08 | AP01 | officers | appoint person director company with name date |
| 2025-12-01 | TM01 | officers | termination director company with name termination date |
| 2025-07-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-10 | AA | accounts | accounts with accounts type full |
| 2025-06-10 | AP01 | officers | appoint person director company with name date |
| 2025-05-23 | AP01 | officers | appoint person director company with name date |
| 2025-05-23 | TM01 | officers | termination director company with name termination date |
| 2024-07-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-04-08 | AA | accounts | accounts with accounts type full |
| 2023-11-15 | TM02 | officers | termination secretary company with name termination date |
| 2023-07-14 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-03-14 | AA | accounts | accounts with accounts type full |
| 2022-07-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-05-31 | AA | accounts | accounts with accounts type full |
| 2021-07-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-07-04 | AA | accounts | accounts with accounts type full |
| 2020-07-20 | CS01 | confirmation-statement | confirmation statement with updates |
| 2020-04-02 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2020-04-01 | AD03 | address | move registers to sail company with new address |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.